Cargando…

Efficacy Studies against PCV-2 of a New Trivalent Vaccine including PCV-2a and PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Weeks of Age

This study aimed to evaluate the efficacy of a new trivalent vaccine containing inactivated Porcine Circovirus 1-2a and 1-2b chimeras and a Mycoplasma hyopneumoniae bacterin administered to pigs around 3 weeks of age. This trivalent vaccine has already been proved as efficacious in a split-dose regi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pleguezuelos, Patricia, Sibila, Marina, Ramírez, Carla, López-Jiménez, Rosa, Pérez, Diego, Huerta, Eva, Llorens, Anna Maria, Pérez, Mónica, Correa-Fiz, Florencia, Mancera Gracia, José Carlos, Taylor, Lucas P., Smith, Jennifer, Bandrick, Meggan, Borowski, Stasia, Saunders, Gillian, Segalés, Joaquim, López-Soria, Sergio, Fort, Maria, Balasch, Mónica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784864/ https://www.ncbi.nlm.nih.gov/pubmed/36560518 http://dx.doi.org/10.3390/vaccines10122108

Ejemplares similares

Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection
por: Pleguezuelos, Patricia, et al.
Publicado: (2022)

One Dose of a Novel Vaccine Containing Two Genotypes of Porcine Circovirus (PCV2a and PCV2b) and Mycoplasma hyopneumoniae Conferred a Duration of Immunity of 23 Weeks
por: Mancera Gracia, José Carlos, et al.
Publicado: (2021)

Safety of the Administration of an Inactivated PCV2a/PCV2b/Mycoplasma Hyopneumoniae Vaccine to Pregnant and Lactating Sows and Gilts
por: Pérez, Elena, et al.
Publicado: (2023)

A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines
por: Bandrick, Meggan, et al.
Publicado: (2022)

Porcine circovirus 2 (PCV2) population study in experimentally infected pigs developing PCV2-systemic disease or a subclinical infection
por: Correa-Fiz, Florencia, et al.
Publicado: (2020)

Exploratory field study on the effects of porcine circovirus 2 (PCV-2) sow vaccination at different physiological stages mimicking blanket vaccination
por: Pleguezuelos, Patricia, et al.
Publicado: (2021)

Detection and genotyping of Porcine circovirus 2 (PCV‐2) and detection of Porcine circovirus 3 (PCV‐3) in sera from fattening pigs of different European countries
por: Saporiti, Viviane, et al.
Publicado: (2020)

Exploratory field study on the effect of Porcine circovirus 2 (PCV2) sow vaccination on serological, virological and reproductive parameters in a PCV2 subclinically infected sow herd
por: Oliver-Ferrando, Salvador, et al.
Publicado: (2018)

Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins
por: Kurtz, Sherry, et al.
Publicado: (2014)

Genotyping of Porcine Circovirus 2 (PCV-2) in Vaccinated Pigs Suffering from PCV-2-Systemic Disease between 2009 and 2020 in Spain
por: Sibila, Marina, et al.
Publicado: (2021)

A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine
por: Yang, Siyeon, et al.
Publicado: (2020)

Frequency of Detection and Phylogenetic Analysis of Porcine circovirus 3 (PCV-3) in Healthy Primiparous and Multiparous Sows and Their Mummified Fetuses and Stillborn
por: Saporiti, Viviane, et al.
Publicado: (2020)

A Comparison of Pathogenicity and Virulence of Three Porcine Circovirus Type 2 (PCV2) Genotypes (a, b, and d) in Pigs Singularly Inoculated with PCV2 and Dually Inoculated with Mycoplasma hyopneumoniae and PCV2
por: Oh, Taehwan, et al.
Publicado: (2021)

Porcine circovirus 3 (PCV‐3) as a causal agent of disease in swine and a proposal of PCV‐3 associated disease case definition
por: Saporiti, Viviane, et al.
Publicado: (2021)

Comparative Evaluation of Growth Performance between Bivalent and Trivalent Vaccines Containing Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae in a Herd with Subclinical PCV2d Infection and Enzootic Pneumonia
por: Um, Hyungmin, et al.
Publicado: (2021)

A Comparative Field Evaluation of the Effect of Growth Performance Between Porcine Circovirus Type 2a (PCV2a)- and PCV2b-Based Bivalent Vaccines Containing PCV2 and Mycoplasma hyopneumoniae
por: Cho, Hyejean, et al.
Publicado: (2022)

Exploratory Study of the Frequency of Detection and Tissue Distribution of Porcine Circovirus 3 (PCV-3) in Pig Fetuses at Different Gestational Ages
por: Ruiz, Albert, et al.
Publicado: (2022)

Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge
por: Seo, Hwi Won, et al.
Publicado: (2014)

Development of a differential multiplex real-time PCR assay for porcine circovirus type 2 (PCV2) genotypes PCV2a, PCV2b and PCV2d
por: Wang, Yin, et al.
Publicado: (2020)

Genotype Shift of Malaysian Porcine Circovirus 2 (PCV2) from PCV2b to PCV2d within a Decade
por: Tan, Chew Yee, et al.
Publicado: (2022)

Effect of Porcine circovirus 2 (PCV-2) maternally derived antibodies on performance and PCV-2 viremia in vaccinated piglets under field conditions
por: Figueras-Gourgues, S., et al.
Publicado: (2019)

Evaluation of natural porcine circovirus type 2 (PCV2) subclinical infection and seroconversion dynamics in piglets vaccinated at different ages
por: Oliver-Ferrando, Salvador, et al.
Publicado: (2016)

Efficacy of Two Commercial Ready-To-Use PCV2 and Mycoplasma hyopneumoniae Vaccines under Field Conditions
por: López-Lorenzo, Gonzalo, et al.
Publicado: (2021)

Evidence of Porcine Circovirus Type 2 (PCV2) Genetic Shift from PCV2b to PCV2d Genotype in Sardinia, Italy
por: Dei Giudici, Silvia, et al.
Publicado: (2023)

The Prevalence and Genetic Diversity of PCV3 and PCV2 in Colombia and PCV4 Survey during 2015–2016 and 2018–2019
por: Vargas-Bermudez, Diana S., et al.
Publicado: (2022)

Porcine circovirus 2 (PCV-2) genetic variability under natural infection scenario reveals a complex network of viral quasispecies
por: Correa-Fiz, Florencia, et al.
Publicado: (2018)

Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets
por: Fort, Maria, et al.
Publicado: (2009)

Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope
por: Mo, Xiaobing, et al.
Publicado: (2019)

First detection of porcine circovirus 4 (PCV-4) in Europe
por: Holgado-Martín, Rocío, et al.
Publicado: (2023)

Descriptive analyses of maternally-derived antibody levels against porcine circovirus 2 (PCV-2) in 3- and 21-day-old piglets from farms of four European countries using different vaccination protocols in sows
por: Sibila, M., et al.
Publicado: (2022)

Establishment and application of a competitive enzyme-linked immunosorbent assay differentiating PCV2 antibodies from mixture of PCV1/PCV2 antibodies in pig sera
por: Han, Shuizhong, et al.
Publicado: (2016)

Current Knowledge on Porcine circovirus 3 (PCV-3): A Novel Virus With a Yet Unknown Impact on the Swine Industry
por: Klaumann, Francini, et al.
Publicado: (2018)

Evaluation of the Efficacy and Cross-Protective Immunity of Live-Attenuated Chimeric PCV1-2b Vaccine Against PCV2b and PCV2d Subtype Challenge in Pigs
por: Huan, Changchao, et al.
Publicado: (2018)

Reproduction in porcine circovirus type 2 (PCV2) seropositive gilts inseminated with PCV2b spiked semen
por: Sarli, Giuseppe, et al.
Publicado: (2012)

Pathological Evaluation of Porcine Circovirus 2d (PCV2d) Strain and Comparative Evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model
por: Noh, Yun-Hee, et al.
Publicado: (2022)

First construction of infectious clone for newly emerging mutation porcine circovirus type 2 (PCV2) followed by comparison with PCV2a and PCV2b genotypes in biological characteristics in vitro
por: Guo, Long J, et al.
Publicado: (2011)

Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge
por: Seo, Hwi Won, et al.
Publicado: (2012)

Efficacy of a Commercial PCV2a Vaccine with a Two-Dose Regimen Against PCV2d
por: Kolyvushko, Oleksandr, et al.
Publicado: (2019)

Selection and Evaluation of Porcine circovirus (PCV) 2d Vaccine Strains to Protect against Currently Prevalent PCV2
por: Ju, Lanjeong, et al.
Publicado: (2023)

Retrospective assessment of porcine circovirus 3 (PCV-3) in formalin-fixed, paraffin-embedded tissues from pigs affected by different clinical-pathological conditions
por: Cobos, Àlex, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gd9ak3slk20dkr2lc19e738t0d